X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5460) 5460
Publication (495) 495
Book Review (105) 105
Book Chapter (88) 88
Newspaper Article (79) 79
Newsletter (30) 30
Conference Proceeding (28) 28
Book / eBook (21) 21
Dissertation (14) 14
Magazine Article (9) 9
Government Document (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3526) 3526
index medicus (3069) 3069
iron (2323) 2323
male (1992) 1992
female (1906) 1906
hematology (1199) 1199
adult (1193) 1193
anemia (1163) 1163
iron overload (1156) 1156
middle aged (1062) 1062
animals (1021) 1021
iron - metabolism (931) 931
ferritin (862) 862
aged (728) 728
oxidative stress (721) 721
mortality (714) 714
risk factors (698) 698
ferritins - blood (694) 694
adolescent (597) 597
health aspects (588) 588
thalassemia (547) 547
oncology (541) 541
child (495) 495
analysis (488) 488
research (484) 484
hemoglobin (480) 480
care and treatment (462) 462
iron chelating agents - therapeutic use (461) 461
liver (457) 457
disease (456) 456
iron - blood (454) 454
inflammation (443) 443
deferoxamine (432) 432
overload (414) 414
metabolism (408) 408
hepcidin (406) 406
beta-thalassemia (405) 405
serum ferritin (401) 401
biochemistry & molecular biology (395) 395
young adult (382) 382
hemochromatosis (375) 375
treatment outcome (364) 364
iron overload - etiology (357) 357
mice (357) 357
blood transfusion (356) 356
diagnosis (348) 348
medicine (344) 344
hereditary hemochromatosis (339) 339
survival (338) 338
patients (334) 334
medicine & public health (330) 330
iron overload - drug therapy (323) 323
homeostasis (318) 318
physiological aspects (317) 317
prevalence (317) 317
therapy (317) 317
risk (316) 316
urology & nephrology (315) 315
magnetic resonance imaging (311) 311
proteins (299) 299
deferasirox (296) 296
cancer (292) 292
prognosis (290) 290
article (288) 288
transplantation (288) 288
pediatrics (286) 286
rats (286) 286
transferrin (283) 283
medicine, general & internal (280) 280
child, preschool (278) 278
transfusion (275) 275
children (270) 270
liver - metabolism (270) 270
pharmacology & pharmacy (267) 267
retrospective studies (267) 267
heart failure (260) 260
prospective studies (259) 259
blood (256) 256
deferiprone (256) 256
studies (254) 254
intravenous iron (251) 251
chelation therapy (250) 250
medical research (250) 250
aged, 80 and over (248) 248
erythropoietin (247) 247
research article (243) 243
mutation (238) 238
cardiac & cardiovascular systems (235) 235
review (234) 234
chelation (230) 230
hemochromatosis - genetics (230) 230
transfusion reaction (225) 225
hemodialysis (224) 224
medicine, research & experimental (224) 224
heart (221) 221
multidisciplinary sciences (221) 221
iron overload - metabolism (219) 219
iron deficiency (218) 218
nutrition & dietetics (217) 217
endocrinology & metabolism (216) 216
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5628) 5628
French (11) 11
German (11) 11
Spanish (6) 6
Chinese (5) 5
Japanese (5) 5
Dutch (3) 3
Korean (3) 3
Turkish (2) 2
Arabic (1) 1
Bulgarian (1) 1
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2013, Volume 161, Issue 6, pp. 794 - 801
Summary This prospective randomized phase II study aimed to determine the safety and efficacy of deferasirox in preventing iatrogenic iron overload in patients... 
iron overload | ferritin | deferasirox | acute myeloid leukaemia | haematopoietic progenitor cell transplantation | Deferasirox | Iron overload | Haematopoietic progenitor cell transplantation | Acute myeloid leukaemia | Ferritin | MORTALITY | PROGNOSTIC IMPACT | INFECTIONS | MYELODYSPLASTIC SYNDROME | INFERIOR SURVIVAL | PRETRANSPLANTATION SERUM FERRITIN | RISK-FACTOR | MUTATIONS | STEM-CELL TRANSPLANTATION | HEMATOLOGY | CHELATION | Benzoates - adverse effects | Recurrence | Triazoles - administration & dosage | Triazoles - adverse effects | Benzoates - therapeutic use | Iron Overload - mortality | Iron Overload - drug therapy | Humans | Middle Aged | Induction Chemotherapy | Male | Consolidation Chemotherapy | Leukemia, Myeloid, Acute - complications | Young Adult | Early Termination of Clinical Trials | Ferritins - blood | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Iron Chelating Agents - administration & dosage | Iatrogenic Disease | Triazoles - therapeutic use | Iron Chelating Agents - therapeutic use | Treatment Outcome | Benzoates - administration & dosage | Iron Chelating Agents - adverse effects | Transfusion Reaction | Iron Overload - complications | Aged | Antimitotic agents | Medical research | Chemotherapy | Medicine, Experimental | Iron | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Seminars in Hematology, ISSN 0037-1963, 2001, Volume 38, Issue 1, pp. 30 - 36
Journal Article
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 5/2012, Volume 91, Issue 5, pp. 743 - 749
Journal Article
Journal of hematology & oncology, ISSN 1756-8722, 2009, Volume 2, Issue 1, pp. 44 - 44
Journal Article
Journal Article